Weight‐Reduction and Safety Profile of Once‐Weekly Non‐Comparable Biotherapeutic Subcutaneous Semaglutide Among People With Obesity: A Real‐World Retrospective Study
A locally available NCB semaglutide in an uncontrolled, real-world setting showed acceptable weight loss and safety profiles among people with obesity.
Authors
- Md Shahed‐Morshed
- Kishore Kumar Shil
Institutions
- Bangladesh University (BD)
- Khulna Medical College (BD)
- Women Medical College (PK)
- Dhaka Medical College and Hospital (BD)
Publication Details
- Journal
- Health Science Reports
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/hsr2.71745
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00